Alerts will be sent to your verified email
Verify Email
RAYLA
|
Cresanto Global
|
Hemo Organic
|
MPS Pharmaa
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.33 % | -343.55 % | -41.86 % |
|
5yr Avg Net Profit Margin
|
0.0 | -766.15 % | -5434.45 % |
|
Price to Book
|
0.0 | 0.0 | 3.7 |
|
P/E
|
0.0 | 42.46 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -1382.2 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-1369.03 | -254.04 | -816.29 |
|
5yr Avg ROCE
|
-157.79 % | 52.28 % | -41.48 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -746.74 % | -3500.38 % |
|
5 yr average Debt to Equity
|
-0.41 | 1.23 | 1.97 |
|
5yr CAGR Net Profit
|
10.76 % | 67.03 % | -6.64 % |
|
5yr Average Return on Assets
|
-51.92 % | -38.14 % | -13.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
32.27 % | 16.85 % | 35.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 16.04 % |
|
Change in Promoter Holding (3 Yrs)
|
3.91 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Cresanto Global
|
Hemo Organic
|
MPS Pharmaa
|
|---|